Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Invested Capital (2019 - 2025)

Tandem Diabetes Care's Return on Invested Capital history spans 7 years, with the latest figure at 1.33% for Q4 2025.

  • For Q4 2025, Return on Invested Capital fell 97.0% year-over-year to 1.33%; the TTM value through Dec 2025 reached 1.33%, down 97.0%, while the annual FY2025 figure was 0.83%, 50.0% down from the prior year.
  • Return on Invested Capital reached 1.33% in Q4 2025 per TNDM's latest filing, up from 1.46% in the prior quarter.
  • In the past five years, Return on Invested Capital ranged from a high of 0.08% in Q3 2021 to a low of 1.46% in Q3 2025.
  • Average Return on Invested Capital over 5 years is 0.48%, with a median of 0.52% recorded in 2023.
  • Peak YoY movement for Return on Invested Capital: surged 40bps in 2024, then crashed -97bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.05% in 2021, then crashed by -508bps to 0.22% in 2022, then crashed by -242bps to 0.75% in 2023, then skyrocketed by 53bps to 0.36% in 2024, then crashed by -273bps to 1.33% in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Return on Invested Capital are 1.33% (Q4 2025), 1.46% (Q3 2025), and 1.23% (Q2 2025).